Regulation of granule cell number by a predetermined number of Purkinje cells in development

Brain Res Dev Brain Res. 1989 Jan 1;45(1):137-47. doi: 10.1016/0165-3806(89)90015-1.

Abstract

Development dysgenesis of Purkinje cells or granule cells was analyzed for the reciprocal effect of reduced number of each cell type on the other. A single pre- or postnatal injection of methylazoxymethanol acetate (MAM) in the rat reduces either the number of Purkinje cells or the number of granule cells when administered at the time of their respective genesis. The total number of these two types of neurons was obtained from cell density values of each layer and the total volume of the granular layer and the area of the Purkinje cell layer. The results show that Purkinje cells (targets) strictly determine the maximum number of granule cells (afferent neurons) following deficits in the number of Purkinje cells produced by prenatal MAM administration. Deficits in Purkinje cells were accompanied by a proportionally smaller number of granule cells so that the ratio remained constant. On the other hand, the reduction in the number of granule cells of the postnatal MAM model did not affect the number of Purkinje cells. These results indicate that the maximum number of these afferent neurons is constrained unidirectionally through a property defined by the number of their target neurons which develop earlier. Furthermore the number of afferent cells had no effect on the number of target cells.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Azo Compounds*
  • Cell Count
  • Cell Differentiation / drug effects
  • Cerebellum / cytology
  • Cerebellum / growth & development*
  • Electronic Data Processing
  • Methylazoxymethanol Acetate*
  • Neuronal Plasticity*
  • Purkinje Cells / cytology
  • Purkinje Cells / physiology*
  • Rats

Substances

  • Azo Compounds
  • Methylazoxymethanol Acetate